Simple Summary Prostate cancer (PCa) is the second most common cancer in males, and
ranks second for cancer death in men. Magnetic resonance imaging (MRI) can detect PCa …

Prostate cancer (PCa) is the most common noncutaneous cancer diagnosed in men
worldwide, accounting for 15% of the total new cancer cases in the male population and …

Background Management of macroscopic local recurrence (MLR) after radical prostatectomy
is a challenging situation with no standardized approach. Objective The objective of our …

Background: The link between hormones and hair growth is well established. Inconsistent
associations have been found between hair patterns and cancer of the prostate, a hormone …

Background Combination of androgen deprivation therapy (ADT) with external beam
radiation therapy (EBRT) is a standard of care for patients with intermediate-risk prostate …

Purpose Utility of prostate-specific antigen density (PSAd) for risk-stratification to avoid
unnecessary biopsy remains unclear due to the lack of standardization of prostate volume …

Background and purpose Extreme hypofractionated stereotactic body radiotherapy (SBRT)
is a therapeutic alternative for localized low-or intermediate-risk prostate cancer. Despite the …

In recent years, various aspects of prostate cancer (PC) management have undergone
significant changes, including the implementation of therapeutic strategies such as the use …

Objective To investigate the mechanism of Yishen Tonglong Decoction (益肾通癃汤, YSTLD)
inhibiting the toll-like receptor 4/p38 mitogen activated protein kinases/nuclear factor kappa …

Prostate cancer is the most common cancer and the third leading cause of cancer mortality
in men. Each year, approximately 10% of prostate cancers are diagnosed metastatic at initial …